Inventory Summary of GenMont Biotech Incorporation

GenMont Biotech Incorporation's latest annual inventory in 2023 was 88.11 Million TWD , up 59.33% from previous year.
GenMont Biotech Incorporation's latest quarterly inventory in 2024 Q1 was 91.7 Million TWD , up 4.07% from previous quarter.
GenMont Biotech Incorporation reported annual inventory of 55.3 Million TWD in 2022, up 49.21% from previous year.
GenMont Biotech Incorporation reported annual inventory of 37.06 Million TWD in 2021, up 6.55% from previous year.
GenMont Biotech Incorporation reported quarterly inventory of 90.23 Million TWD for 2024 Q2, down -1.6% from previous quarter.
GenMont Biotech Incorporation reported quarterly inventory of 88.11 Million TWD for 2023 Q4, up 18.16% from previous quarter.

Annual Inventory Chart of GenMont Biotech Incorporation (2023 - 2009)

Historical Annual Inventory of GenMont Biotech Incorporation (2023 - 2009)

Year	Inventory	Inventory Growth
2023	88.11 Million TWD	59.33%
2022	55.3 Million TWD	49.21%
2021	37.06 Million TWD	6.55%
2020	34.78 Million TWD	10.5%
2019	31.48 Million TWD	-22.21%
2018	40.46 Million TWD	-40.08%
2017	67.53 Million TWD	9.86%
2016	61.47 Million TWD	12.87%
2015	54.46 Million TWD	1.42%
2014	53.7 Million TWD	216.14%
2013	16.98 Million TWD	-4.81%
2012	17.84 Million TWD	29.47%
2011	13.78 Million TWD	-22.24%
2010	17.72 Million TWD	14.43%
2009	15.49 Million TWD	0.0%

Year	Inventory	Inventory Growth
2024 Q1	91.7 Million TWD	4.07%
2024 Q2	90.23 Million TWD	-1.6%
2023 Q4	88.11 Million TWD	18.16%
2023 FY	88.11 Million TWD	59.33%
2023 Q2	66.96 Million TWD	6.05%
2023 Q3	74.57 Million TWD	11.37%
2023 Q1	63.14 Million TWD	14.17%
2022 Q1	43.82 Million TWD	18.24%
2022 Q2	42.78 Million TWD	-2.38%
2022 FY	55.3 Million TWD	49.21%
2022 Q4	55.3 Million TWD	25.32%
2022 Q3	44.12 Million TWD	3.15%
2021 FY	37.06 Million TWD	6.55%
2021 Q1	34.22 Million TWD	-1.6%
2021 Q2	32.42 Million TWD	-5.28%
2021 Q3	32.32 Million TWD	-0.31%
2021 Q4	37.06 Million TWD	14.67%
2020 Q2	33.32 Million TWD	-7.67%
2020 Q3	39.4 Million TWD	18.25%
2020 Q4	34.78 Million TWD	-11.72%
2020 Q1	36.09 Million TWD	14.65%
2020 FY	34.78 Million TWD	10.5%
2019 Q1	32.24 Million TWD	-20.31%
2019 Q3	35.98 Million TWD	4.78%
2019 Q4	31.48 Million TWD	-12.51%
2019 FY	31.48 Million TWD	-22.21%
2019 Q2	34.33 Million TWD	6.49%
2018 Q2	45.59 Million TWD	-34.72%
2018 Q4	40.46 Million TWD	3.95%
2018 FY	40.46 Million TWD	-40.08%
2018 Q1	69.84 Million TWD	3.41%
2018 Q3	38.92 Million TWD	-14.62%
2017 Q2	58.65 Million TWD	1.77%
2017 FY	67.53 Million TWD	9.86%
2017 Q4	67.53 Million TWD	-0.71%
2017 Q3	68.02 Million TWD	15.96%
2017 Q1	57.63 Million TWD	-6.25%
2016 Q1	61.2 Million TWD	12.37%
2016 Q2	61.52 Million TWD	0.51%
2016 Q3	57.18 Million TWD	-7.05%
2016 Q4	61.47 Million TWD	7.51%
2016 FY	61.47 Million TWD	12.87%
2015 Q1	50.09 Million TWD	-6.72%
2015 Q3	59.68 Million TWD	30.21%
2015 Q2	45.83 Million TWD	-8.5%
2015 FY	54.46 Million TWD	1.42%
2015 Q4	54.46 Million TWD	-8.74%
2014 Q4	53.7 Million TWD	0.47%
2014 FY	53.7 Million TWD	216.14%
2014 Q2	75.67 Million TWD	-4.44%
2014 Q3	53.45 Million TWD	-29.37%
2014 Q1	79.19 Million TWD	366.16%
2013 Q2	18.64 Million TWD	-3.08%
2013 Q3	15.19 Million TWD	-18.48%
2013 Q4	16.98 Million TWD	11.79%
2013 FY	16.98 Million TWD	-4.81%
2013 Q1	19.23 Million TWD	7.77%
2012 Q4	17.84 Million TWD	9.02%
2012 Q3	16.36 Million TWD	-11.23%
2012 Q2	18.44 Million TWD	-9.54%
2012 Q1	20.38 Million TWD	47.88%
2012 FY	17.84 Million TWD	29.47%
2011 Q1	20.61 Million TWD	16.32%
2011 Q2	19.48 Million TWD	-5.5%
2011 Q3	21.66 Million TWD	11.17%
2011 Q4	13.78 Million TWD	-36.36%
2011 FY	13.78 Million TWD	-22.24%
2010 FY	17.72 Million TWD	14.43%
2010 Q4	17.72 Million TWD	0.0%
2009 FY	15.49 Million TWD	0.0%

Peer Inventory Comparison of GenMont Biotech Incorporation

Name	Inventory	Inventory Difference
Apex Biotechnology Corp.	747.71 Million TWD	88.215%
Sinphar Pharmaceutical Co.,Ltd.	839.19 Million TWD	89.5%
Panion & Bf Biotech Inc.	538.09 Million TWD	83.624%
Chunghwa Chemical Synthesis & Biotech Co., Ltd.	1.21 Billion TWD	92.724%
Abnova (Taiwan) Corporation	408.3 Million TWD	78.418%
Adimmune Corporation	526.4 Million TWD	83.26%
Tanvex BioPharma, Inc.	108.28 Million TWD	18.624%
Polaris Group	36.35 Million TWD	-142.382%
Energenesis Biomedical CO.,LTD.	733 Thousand TWD	-11921.555%
UnicoCell Biomed Co., Ltd.	5.45 Million TWD	-1516.547%
PELL Bio-Med Technology Co. Ltd.	3.76 Million TWD	-2241.695%

Global Stocks Search

GenMont Biotech Incorporation (3164.TW)

Inventory Summary of GenMont Biotech Incorporation

Annual Inventory Chart of GenMont Biotech Incorporation (2023 - 2009)

Historical Annual Inventory of GenMont Biotech Incorporation (2023 - 2009)

Peer Inventory Comparison of GenMont Biotech Incorporation